ProKidney GAAP EPS of -$0.62

• ProKidney press release (NASDAQ:PROK): FY GAAP EPS of -$0.62.

• Net Loss Before Noncontrolling Interest: Net loss before noncontrolling interest was $163.3 million and $135.4 million for the years ended December 31, 2024, and 2023, respectively.

  Shares outstanding: Class A and Class B ordinary shares outstanding at December 31, 2024 totaled 291,748,124.

•  

More on ProKidney

• 2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment
• Seeking Alpha’s Quant Rating on ProKidney
• Historical earnings data for ProKidney
• Financial information for ProKidney